Currently, placebo-controlled clinical trials report mean change and effect sizes, which masks information about heterogeneity of treatment effects (HTE). Here, we present a novel method to estimate HTE and evaluate the null hypothesis (H(0)) that a drug has equal benefit for all participants (HTE = 0). We developed a measure termed ‘estimated heterogeneity of treatment effect’ or eHTE, which compares the distributions between study arms to test for heterogeneity in drug response – rather than…
